By Jennifer Rigby

LONDON (Reuters) -The World Health Organization will recommend using weight-loss drugs to treat obesity in adults, according to draft guidance from the agency that urged countries to take the condition seriously as a chronic disease.

The WHO’s expert committee concluded that the popular GLP-1 drugs, first developed by Novo Nordisk and Eli Lilly, are part of the solution for the long-term treatment of obesity for patients with a body mass index (BMI) of 30 or above, alongside counselling on lifestyle and behaviour changes.

Reuters first reported that the WHO was likely to take this step in May this year.

In the draft guidelines, which were published online and are open for consultation until September 27, the WHO said the response to obesity was often shaped by outdate

See Full Page